Abstract
•Immune therapy is increasingly used in the treatment of gynecologic malignancies. •Early recognition and appropriate management of immune-related toxicity is critical. •Special considerations for immune therapy in gynecologic malignancies are reviewed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
